<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DrugDDI.d269" origId="Vardenafil"><sentence id="DrugDDI.d269.s0" origId="s0" text="Effect of other drugs on Vardenafil"><entity charOffset="16-21" id="DrugDDI.d269.s0.e0" origId="s0.p1" text="drugs" type="drug"/><entity charOffset="25-35" id="DrugDDI.d269.s0.e1" origId="s0.p2" text="Vardenafil" type="drug"/><pair e1="DrugDDI.d269.s0.e0" e2="DrugDDI.d269.s0.e1" id="DrugDDI.d269.s0.p0" interaction="false"/></sentence><sentence id="DrugDDI.d269.s1" origId="s1" text="In vitro studies: Studies in human liver microsomes showed that vardenafil is metabolized primarily by cytochrome P450 (CYP) isoforms 3A4/5, and to a lesser degree by CYP2C9."><entity charOffset="64-74" id="DrugDDI.d269.s1.e0" origId="s1.p8" text="vardenafil" type="drug"/><entity charOffset="103-118" id="DrugDDI.d269.s1.e1" origId="s1.p12" text="cytochrome P450" type="drug"/><entity charOffset="120-123" id="DrugDDI.d269.s1.e2" origId="s1.p14" text="CYP" type="drug"/><entity charOffset="125-133" id="DrugDDI.d269.s1.e3" origId="s1.p16" text="isoforms" type="drug"/><entity charOffset="167-173" id="DrugDDI.d269.s1.e4" origId="s1.p20" text="CYP2C9" type="drug"/><pair e1="DrugDDI.d269.s1.e0" e2="DrugDDI.d269.s1.e1" id="DrugDDI.d269.s1.p0" interaction="false"/><pair e1="DrugDDI.d269.s1.e0" e2="DrugDDI.d269.s1.e2" id="DrugDDI.d269.s1.p1" interaction="false"/><pair e1="DrugDDI.d269.s1.e0" e2="DrugDDI.d269.s1.e3" id="DrugDDI.d269.s1.p2" interaction="false"/><pair e1="DrugDDI.d269.s1.e0" e2="DrugDDI.d269.s1.e4" id="DrugDDI.d269.s1.p3" interaction="false"/><pair e1="DrugDDI.d269.s1.e1" e2="DrugDDI.d269.s1.e2" id="DrugDDI.d269.s1.p4" interaction="false"/><pair e1="DrugDDI.d269.s1.e1" e2="DrugDDI.d269.s1.e3" id="DrugDDI.d269.s1.p5" interaction="false"/><pair e1="DrugDDI.d269.s1.e1" e2="DrugDDI.d269.s1.e4" id="DrugDDI.d269.s1.p6" interaction="false"/><pair e1="DrugDDI.d269.s1.e2" e2="DrugDDI.d269.s1.e3" id="DrugDDI.d269.s1.p7" interaction="false"/><pair e1="DrugDDI.d269.s1.e2" e2="DrugDDI.d269.s1.e4" id="DrugDDI.d269.s1.p8" interaction="false"/><pair e1="DrugDDI.d269.s1.e3" e2="DrugDDI.d269.s1.e4" id="DrugDDI.d269.s1.p9" interaction="false"/></sentence><sentence id="DrugDDI.d269.s2" origId="s2" text="Therefore, inhibitors of these enzymes are expected to reduce vardenafil clearance."><entity charOffset="62-72" id="DrugDDI.d269.s2.e0" origId="s2.p28" text="vardenafil" type="drug"/></sentence><sentence id="DrugDDI.d269.s3" origId="s3" text="In vivo studies: Cytochrome P450 Inhibitors"><entity charOffset="17-32" id="DrugDDI.d269.s3.e0" origId="s3.p31" text="Cytochrome P450" type="drug"/></sentence><sentence id="DrugDDI.d269.s4" origId="s4" text="Cimetidine (400 mg b.i.d.) had no effect on vardenafil bioavailability (AUC) and maximum concentration (Cmax) of vardenafil when co-administered with 20 mg Vardenafil in healthy volunteers."><entity charOffset="0-10" id="DrugDDI.d269.s4.e0" origId="s4.p32" text="Cimetidine" type="drug"/><entity charOffset="44-54" id="DrugDDI.d269.s4.e1" origId="s4.p38" text="vardenafil" type="drug"/><entity charOffset="113-123" id="DrugDDI.d269.s4.e2" origId="s4.p47" text="vardenafil" type="drug"/><entity charOffset="156-166" id="DrugDDI.d269.s4.e3" origId="s4.p50" text="Vardenafil" type="drug"/><pair e1="DrugDDI.d269.s4.e0" e2="DrugDDI.d269.s4.e1" id="DrugDDI.d269.s4.p0" interaction="false"/><pair e1="DrugDDI.d269.s4.e0" e2="DrugDDI.d269.s4.e2" id="DrugDDI.d269.s4.p1" interaction="false"/><pair e1="DrugDDI.d269.s4.e0" e2="DrugDDI.d269.s4.e3" id="DrugDDI.d269.s4.p2" interaction="false"/><pair e1="DrugDDI.d269.s4.e1" e2="DrugDDI.d269.s4.e2" id="DrugDDI.d269.s4.p3" interaction="false"/><pair e1="DrugDDI.d269.s4.e1" e2="DrugDDI.d269.s4.e3" id="DrugDDI.d269.s4.p4" interaction="false"/><pair e1="DrugDDI.d269.s4.e2" e2="DrugDDI.d269.s4.e3" id="DrugDDI.d269.s4.p5" interaction="false"/><negationtags>Cimetidine (400 mg b.i.d.) had &lt;xcope&gt;&lt;cue&gt;no&lt;/cue&gt; effect on vardenafil bioavailability (AUC) and maximum concentration (Cmax) of vardenafil when co-administered with 20 mg Vardenafil in healthy volunteers&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d269.s5" origId="s5" text="Erythromycin (500 mg t.i.d) produced a 4-fold increase in vardenafil AUC and a 3-fold increase in Cmax when co-administered with Vardenafil 5 mg in healthy volunteers."><entity charOffset="0-12" id="DrugDDI.d269.s5.e0" origId="s5.p52" text="Erythromycin" type="drug"/><entity charOffset="14-18" id="DrugDDI.d269.s5.e1" origId="s5.p54" text="500" type="drug"/><entity charOffset="58-68" id="DrugDDI.d269.s5.e2" origId="s5.p58" text="vardenafil" type="drug"/><entity charOffset="129-144" id="DrugDDI.d269.s5.e3" origId="s5.p64" text="Vardenafil 5 mg" type="drug"/><pair e1="DrugDDI.d269.s5.e0" e2="DrugDDI.d269.s5.e1" id="DrugDDI.d269.s5.p0" interaction="false"/><pair e1="DrugDDI.d269.s5.e0" e2="DrugDDI.d269.s5.e2" id="DrugDDI.d269.s5.p1" interaction="true"/><pair e1="DrugDDI.d269.s5.e0" e2="DrugDDI.d269.s5.e3" id="DrugDDI.d269.s5.p2" interaction="false"/><pair e1="DrugDDI.d269.s5.e1" e2="DrugDDI.d269.s5.e2" id="DrugDDI.d269.s5.p3" interaction="false"/><pair e1="DrugDDI.d269.s5.e1" e2="DrugDDI.d269.s5.e3" id="DrugDDI.d269.s5.p4" interaction="false"/><pair e1="DrugDDI.d269.s5.e2" e2="DrugDDI.d269.s5.e3" id="DrugDDI.d269.s5.p5" interaction="false"/></sentence><sentence id="DrugDDI.d269.s6" origId="s6" text="It is recommended not to exceed a single 5 mg dose of Vardenafil in a 24-hour period when used in combination with erythromycin."><entity charOffset="54-64" id="DrugDDI.d269.s6.e0" origId="s6.p72" text="Vardenafil" type="drug"/><entity charOffset="115-127" id="DrugDDI.d269.s6.e1" origId="s6.p77" text="erythromycin" type="drug"/><pair e1="DrugDDI.d269.s6.e0" e2="DrugDDI.d269.s6.e1" id="DrugDDI.d269.s6.p0" interaction="true"/><negationtags>It is recommended &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; to exceed a single 5 mg dose of Vardenafil in a 24-hour period when used in combination with erythromycin&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d269.s7" origId="s7" text="Ketoconazole (200 mg once daily) produced a 10-fold increase in vardenafil AUC and a 4-fold increase in Cmax when co-administered with Vardenafil (5 mg) in healthy volunteers."><entity charOffset="0-12" id="DrugDDI.d269.s7.e0" origId="s7.p78" text="Ketoconazole" type="drug"/><entity charOffset="64-74" id="DrugDDI.d269.s7.e1" origId="s7.p85" text="vardenafil" type="drug"/><entity charOffset="135-145" id="DrugDDI.d269.s7.e2" origId="s7.p91" text="Vardenafil" type="drug"/><pair e1="DrugDDI.d269.s7.e0" e2="DrugDDI.d269.s7.e1" id="DrugDDI.d269.s7.p0" interaction="true"/><pair e1="DrugDDI.d269.s7.e0" e2="DrugDDI.d269.s7.e2" id="DrugDDI.d269.s7.p1" interaction="false"/><pair e1="DrugDDI.d269.s7.e1" e2="DrugDDI.d269.s7.e2" id="DrugDDI.d269.s7.p2" interaction="false"/></sentence><sentence id="DrugDDI.d269.s8" origId="s8" text="A 5-mg Vardenafil dose should not be exceeded when used in combination with 200 mg once daily ketoconazole."><entity charOffset="7-17" id="DrugDDI.d269.s8.e0" origId="s8.p96" text="Vardenafil" type="drug"/><entity charOffset="94-106" id="DrugDDI.d269.s8.e1" origId="s8.p105" text="ketoconazole" type="drug"/><pair e1="DrugDDI.d269.s8.e0" e2="DrugDDI.d269.s8.e1" id="DrugDDI.d269.s8.p0" interaction="true"/><negationtags>A 5-mg Vardenafil dose should &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; be exceeded when used in combination with 200 mg once daily ketoconazole&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d269.s9" origId="s9" text="Since higher doses of ketoconazole (400 mg daily) may result in higher increases in Cmax and AUC, a single 2.5 mg dose of Vardenafil should not be exceeded in a 24-hour period when used in combination with ketoconazole 400 mg daily."><entity charOffset="22-34" id="DrugDDI.d269.s9.e0" origId="s9.p107" text="ketoconazole" type="drug"/><entity charOffset="122-132" id="DrugDDI.d269.s9.e1" origId="s9.p118" text="Vardenafil" type="drug"/><entity charOffset="206-225" id="DrugDDI.d269.s9.e2" origId="s9.p127" text="ketoconazole 400 mg" type="drug"/><pair e1="DrugDDI.d269.s9.e0" e2="DrugDDI.d269.s9.e1" id="DrugDDI.d269.s9.p0" interaction="true"/><pair e1="DrugDDI.d269.s9.e0" e2="DrugDDI.d269.s9.e2" id="DrugDDI.d269.s9.p1" interaction="false"/><pair e1="DrugDDI.d269.s9.e1" e2="DrugDDI.d269.s9.e2" id="DrugDDI.d269.s9.p2" interaction="false"/><negationtags>Since higher doses of ketoconazole (400 mg daily) may result in higher increases in Cmax and AUC, a single 2.5 mg dose of Vardenafil should &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; be exceeded in a 24-hour period when used in combination with ketoconazole 400 mg daily&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d269.s10" origId="s10" text="HIV Protease Inhibitors: Indinavir (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life."><entity charOffset="0-23" id="DrugDDI.d269.s10.e0" origId="s10.p128" text="HIV Protease Inhibitors" type="drug"/><entity charOffset="25-34" id="DrugDDI.d269.s10.e1" origId="s10.p130" text="Indinavir" type="drug"/><entity charOffset="36-40" id="DrugDDI.d269.s10.e2" origId="s10.p132" text="800" type="drug"/><entity charOffset="72-88" id="DrugDDI.d269.s10.e3" origId="s10.p135" text="Vardenafil 10 mg" type="drug"/><entity charOffset="123-133" id="DrugDDI.d269.s10.e4" origId="s10.p138" text="vardenafil" type="drug"/><entity charOffset="160-170" id="DrugDDI.d269.s10.e5" origId="s10.p140" text="vardenafil" type="drug"/><entity charOffset="201-211" id="DrugDDI.d269.s10.e6" origId="s10.p143" text="vardenafil" type="drug"/><pair e1="DrugDDI.d269.s10.e0" e2="DrugDDI.d269.s10.e1" id="DrugDDI.d269.s10.p0" interaction="false"/><pair e1="DrugDDI.d269.s10.e0" e2="DrugDDI.d269.s10.e2" id="DrugDDI.d269.s10.p1" interaction="false"/><pair e1="DrugDDI.d269.s10.e0" e2="DrugDDI.d269.s10.e3" id="DrugDDI.d269.s10.p2" interaction="false"/><pair e1="DrugDDI.d269.s10.e0" e2="DrugDDI.d269.s10.e4" id="DrugDDI.d269.s10.p3" interaction="false"/><pair e1="DrugDDI.d269.s10.e0" e2="DrugDDI.d269.s10.e5" id="DrugDDI.d269.s10.p4" interaction="false"/><pair e1="DrugDDI.d269.s10.e0" e2="DrugDDI.d269.s10.e6" id="DrugDDI.d269.s10.p5" interaction="false"/><pair e1="DrugDDI.d269.s10.e1" e2="DrugDDI.d269.s10.e2" id="DrugDDI.d269.s10.p6" interaction="false"/><pair e1="DrugDDI.d269.s10.e1" e2="DrugDDI.d269.s10.e3" id="DrugDDI.d269.s10.p7" interaction="true"/><pair e1="DrugDDI.d269.s10.e1" e2="DrugDDI.d269.s10.e4" id="DrugDDI.d269.s10.p8" interaction="false"/><pair e1="DrugDDI.d269.s10.e1" e2="DrugDDI.d269.s10.e5" id="DrugDDI.d269.s10.p9" interaction="false"/><pair e1="DrugDDI.d269.s10.e1" e2="DrugDDI.d269.s10.e6" id="DrugDDI.d269.s10.p10" interaction="false"/><pair e1="DrugDDI.d269.s10.e2" e2="DrugDDI.d269.s10.e3" id="DrugDDI.d269.s10.p11" interaction="false"/><pair e1="DrugDDI.d269.s10.e2" e2="DrugDDI.d269.s10.e4" id="DrugDDI.d269.s10.p12" interaction="false"/><pair e1="DrugDDI.d269.s10.e2" e2="DrugDDI.d269.s10.e5" id="DrugDDI.d269.s10.p13" interaction="false"/><pair e1="DrugDDI.d269.s10.e2" e2="DrugDDI.d269.s10.e6" id="DrugDDI.d269.s10.p14" interaction="false"/><pair e1="DrugDDI.d269.s10.e3" e2="DrugDDI.d269.s10.e4" id="DrugDDI.d269.s10.p15" interaction="false"/><pair e1="DrugDDI.d269.s10.e3" e2="DrugDDI.d269.s10.e5" id="DrugDDI.d269.s10.p16" interaction="false"/><pair e1="DrugDDI.d269.s10.e3" e2="DrugDDI.d269.s10.e6" id="DrugDDI.d269.s10.p17" interaction="false"/><pair e1="DrugDDI.d269.s10.e4" e2="DrugDDI.d269.s10.e5" id="DrugDDI.d269.s10.p18" interaction="false"/><pair e1="DrugDDI.d269.s10.e4" e2="DrugDDI.d269.s10.e6" id="DrugDDI.d269.s10.p19" interaction="false"/><pair e1="DrugDDI.d269.s10.e5" e2="DrugDDI.d269.s10.e6" id="DrugDDI.d269.s10.p20" interaction="false"/></sentence><sentence id="DrugDDI.d269.s11" origId="s11" text="It is recommended not to exceed a single 2.5 mg Vardenafil dose in a 24-hour period when used in combination with indinavir."><entity charOffset="114-123" id="DrugDDI.d269.s11.e0" origId="s11.p154" text="indinavir" type="drug"/><negationtags>It is recommended &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; to exceed a single 2.5 mg Vardenafil dose in a 24-hour period when used in combination with indinavir&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d269.s12" origId="s12" text="Ritonavir (600 mg b.i.d.) co-administered with Vardenafil 5 mg resulted in a 49-fold increase in vardenafil AUC and a 13-fold increase in vardenafil Cmax."><entity charOffset="0-9" id="DrugDDI.d269.s12.e0" origId="s12.p155" text="Ritonavir" type="drug"/><entity charOffset="47-62" id="DrugDDI.d269.s12.e1" origId="s12.p160" text="Vardenafil 5 mg" type="drug"/><entity charOffset="97-107" id="DrugDDI.d269.s12.e2" origId="s12.p163" text="vardenafil" type="drug"/><entity charOffset="138-148" id="DrugDDI.d269.s12.e3" origId="s12.p166" text="vardenafil" type="drug"/><pair e1="DrugDDI.d269.s12.e0" e2="DrugDDI.d269.s12.e1" id="DrugDDI.d269.s12.p0" interaction="true"/><pair e1="DrugDDI.d269.s12.e0" e2="DrugDDI.d269.s12.e2" id="DrugDDI.d269.s12.p1" interaction="false"/><pair e1="DrugDDI.d269.s12.e0" e2="DrugDDI.d269.s12.e3" id="DrugDDI.d269.s12.p2" interaction="false"/><pair e1="DrugDDI.d269.s12.e1" e2="DrugDDI.d269.s12.e2" id="DrugDDI.d269.s12.p3" interaction="false"/><pair e1="DrugDDI.d269.s12.e1" e2="DrugDDI.d269.s12.e3" id="DrugDDI.d269.s12.p4" interaction="false"/><pair e1="DrugDDI.d269.s12.e2" e2="DrugDDI.d269.s12.e3" id="DrugDDI.d269.s12.p5" interaction="false"/></sentence><sentence id="DrugDDI.d269.s13" origId="s13" text="The interaction is a consequence of blocking hepatic metabolism of vardenafil by ritonavir, a highly potent CYP3A4 inhibitor, which also inhibits CYP2C9."><entity charOffset="67-77" id="DrugDDI.d269.s13.e0" origId="s13.p171" text="vardenafil" type="drug"/><entity charOffset="81-90" id="DrugDDI.d269.s13.e1" origId="s13.p172" text="ritonavir" type="drug"/><entity charOffset="108-114" id="DrugDDI.d269.s13.e2" origId="s13.p173" text="CYP3A4" type="drug"/><entity charOffset="146-152" id="DrugDDI.d269.s13.e3" origId="s13.p176" text="CYP2C9" type="drug"/><pair e1="DrugDDI.d269.s13.e0" e2="DrugDDI.d269.s13.e1" id="DrugDDI.d269.s13.p0" interaction="true"/><pair e1="DrugDDI.d269.s13.e0" e2="DrugDDI.d269.s13.e2" id="DrugDDI.d269.s13.p1" interaction="false"/><pair e1="DrugDDI.d269.s13.e0" e2="DrugDDI.d269.s13.e3" id="DrugDDI.d269.s13.p2" interaction="false"/><pair e1="DrugDDI.d269.s13.e1" e2="DrugDDI.d269.s13.e2" id="DrugDDI.d269.s13.p3" interaction="false"/><pair e1="DrugDDI.d269.s13.e1" e2="DrugDDI.d269.s13.e3" id="DrugDDI.d269.s13.p4" interaction="false"/><pair e1="DrugDDI.d269.s13.e2" e2="DrugDDI.d269.s13.e3" id="DrugDDI.d269.s13.p5" interaction="false"/></sentence><sentence id="DrugDDI.d269.s14" origId="s14" text="Ritonavir significantly prolonged the half-life of vardenafil to 26 hours."><entity charOffset="0-9" id="DrugDDI.d269.s14.e0" origId="s14.p177" text="Ritonavir" type="drug"/><entity charOffset="51-61" id="DrugDDI.d269.s14.e1" origId="s14.p180" text="vardenafil" type="drug"/><pair e1="DrugDDI.d269.s14.e0" e2="DrugDDI.d269.s14.e1" id="DrugDDI.d269.s14.p0" interaction="true"/></sentence><sentence id="DrugDDI.d269.s15" origId="s15" text="Consequently, it is recommended not to exceed a single 2.5 mg Vardenafil dose in a 72-hour period when used in combination with ritonavir."><entity charOffset="128-137" id="DrugDDI.d269.s15.e0" origId="s15.p193" text="ritonavir" type="drug"/><negationtags>Consequently, it is recommended &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; to exceed a single 2.5 mg Vardenafil dose in a 72-hour period when used in combination with ritonavir&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d269.s16" origId="s16" text="Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: glyburide, warfarin, digoxin, Maalox, and ranitidine."><entity charOffset="79-89" id="DrugDDI.d269.s16.e0" origId="s16.p199" text="vardenafil" type="drug"/><entity charOffset="108-113" id="DrugDDI.d269.s16.e1" origId="s16.p201" text="drugs" type="drug"/><entity charOffset="115-124" id="DrugDDI.d269.s16.e2" origId="s16.p203" text="glyburide" type="drug"/><entity charOffset="126-134" id="DrugDDI.d269.s16.e3" origId="s16.p204" text="warfarin" type="drug"/><entity charOffset="136-143" id="DrugDDI.d269.s16.e4" origId="s16.p205" text="digoxin" type="drug"/><entity charOffset="145-151" id="DrugDDI.d269.s16.e5" origId="s16.p206" text="Maalox" type="drug"/><entity charOffset="157-167" id="DrugDDI.d269.s16.e6" origId="s16.p208" text="ranitidine" type="drug"/><pair e1="DrugDDI.d269.s16.e0" e2="DrugDDI.d269.s16.e1" id="DrugDDI.d269.s16.p0" interaction="false"/><pair e1="DrugDDI.d269.s16.e0" e2="DrugDDI.d269.s16.e2" id="DrugDDI.d269.s16.p1" interaction="false"/><pair e1="DrugDDI.d269.s16.e0" e2="DrugDDI.d269.s16.e3" id="DrugDDI.d269.s16.p2" interaction="false"/><pair e1="DrugDDI.d269.s16.e0" e2="DrugDDI.d269.s16.e4" id="DrugDDI.d269.s16.p3" interaction="false"/><pair e1="DrugDDI.d269.s16.e0" e2="DrugDDI.d269.s16.e5" id="DrugDDI.d269.s16.p4" interaction="false"/><pair e1="DrugDDI.d269.s16.e0" e2="DrugDDI.d269.s16.e6" id="DrugDDI.d269.s16.p5" interaction="false"/><pair e1="DrugDDI.d269.s16.e1" e2="DrugDDI.d269.s16.e2" id="DrugDDI.d269.s16.p6" interaction="false"/><pair e1="DrugDDI.d269.s16.e1" e2="DrugDDI.d269.s16.e3" id="DrugDDI.d269.s16.p7" interaction="false"/><pair e1="DrugDDI.d269.s16.e1" e2="DrugDDI.d269.s16.e4" id="DrugDDI.d269.s16.p8" interaction="false"/><pair e1="DrugDDI.d269.s16.e1" e2="DrugDDI.d269.s16.e5" id="DrugDDI.d269.s16.p9" interaction="false"/><pair e1="DrugDDI.d269.s16.e1" e2="DrugDDI.d269.s16.e6" id="DrugDDI.d269.s16.p10" interaction="false"/><pair e1="DrugDDI.d269.s16.e2" e2="DrugDDI.d269.s16.e3" id="DrugDDI.d269.s16.p11" interaction="false"/><pair e1="DrugDDI.d269.s16.e2" e2="DrugDDI.d269.s16.e4" id="DrugDDI.d269.s16.p12" interaction="false"/><pair e1="DrugDDI.d269.s16.e2" e2="DrugDDI.d269.s16.e5" id="DrugDDI.d269.s16.p13" interaction="false"/><pair e1="DrugDDI.d269.s16.e2" e2="DrugDDI.d269.s16.e6" id="DrugDDI.d269.s16.p14" interaction="false"/><pair e1="DrugDDI.d269.s16.e3" e2="DrugDDI.d269.s16.e4" id="DrugDDI.d269.s16.p15" interaction="false"/><pair e1="DrugDDI.d269.s16.e3" e2="DrugDDI.d269.s16.e5" id="DrugDDI.d269.s16.p16" interaction="false"/><pair e1="DrugDDI.d269.s16.e3" e2="DrugDDI.d269.s16.e6" id="DrugDDI.d269.s16.p17" interaction="false"/><pair e1="DrugDDI.d269.s16.e4" e2="DrugDDI.d269.s16.e5" id="DrugDDI.d269.s16.p18" interaction="false"/><pair e1="DrugDDI.d269.s16.e4" e2="DrugDDI.d269.s16.e6" id="DrugDDI.d269.s16.p19" interaction="false"/><pair e1="DrugDDI.d269.s16.e5" e2="DrugDDI.d269.s16.e6" id="DrugDDI.d269.s16.p20" interaction="false"/><negationtags>Other Drug Interactions: &lt;xcope&gt;&lt;cue&gt;No&lt;/cue&gt; pharmacokinetic interactions were observed between vardenafil and the following drugs: glyburide&lt;/xcope&gt;, warfarin, digoxin, Maalox, and ranitidine.</negationtags></sentence><sentence id="DrugDDI.d269.s17" origId="s17" text="In the warfarin study, vardenafil had no effect on the prothrombin time or other pharmacodynamic parameters."><entity charOffset="7-15" id="DrugDDI.d269.s17.e0" origId="s17.p209" text="warfarin" type="drug"/><entity charOffset="23-33" id="DrugDDI.d269.s17.e1" origId="s17.p210" text="vardenafil" type="drug"/><pair e1="DrugDDI.d269.s17.e0" e2="DrugDDI.d269.s17.e1" id="DrugDDI.d269.s17.p0" interaction="false"/><negationtags>In the warfarin study, vardenafil had &lt;xcope&gt;&lt;cue&gt;no&lt;/cue&gt; effect on the prothrombin time or other pharmacodynamic parameters&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d269.s18" origId="s18" text="Effects of Vardenafil on other drugs"><entity charOffset="11-21" id="DrugDDI.d269.s18.e0" origId="s18.p217" text="Vardenafil" type="drug"/><entity charOffset="31-36" id="DrugDDI.d269.s18.e1" origId="s18.p218" text="drugs" type="drug"/><pair e1="DrugDDI.d269.s18.e0" e2="DrugDDI.d269.s18.e1" id="DrugDDI.d269.s18.p0" interaction="false"/></sentence><sentence id="DrugDDI.d269.s19" origId="s19" text="In vitro studies: Vardenafil and its metabolites had no effect on CYP1A2, 2A6, and 2E1 (Ki   100uM)."><entity charOffset="18-28" id="DrugDDI.d269.s19.e0" origId="s19.p221" text="Vardenafil" type="drug"/><entity charOffset="37-48" id="DrugDDI.d269.s19.e1" origId="s19.p223" text="metabolites" type="drug"/><entity charOffset="66-72" id="DrugDDI.d269.s19.e2" origId="s19.p226" text="CYP1A2" type="drug"/><entity charOffset="88-99" id="DrugDDI.d269.s19.e3" origId="s19.p231" text="Ki   100uM" type="drug"/><pair e1="DrugDDI.d269.s19.e0" e2="DrugDDI.d269.s19.e1" id="DrugDDI.d269.s19.p0" interaction="false"/><pair e1="DrugDDI.d269.s19.e0" e2="DrugDDI.d269.s19.e2" id="DrugDDI.d269.s19.p1" interaction="false"/><pair e1="DrugDDI.d269.s19.e0" e2="DrugDDI.d269.s19.e3" id="DrugDDI.d269.s19.p2" interaction="false"/><pair e1="DrugDDI.d269.s19.e1" e2="DrugDDI.d269.s19.e2" id="DrugDDI.d269.s19.p3" interaction="false"/><pair e1="DrugDDI.d269.s19.e1" e2="DrugDDI.d269.s19.e3" id="DrugDDI.d269.s19.p4" interaction="false"/><pair e1="DrugDDI.d269.s19.e2" e2="DrugDDI.d269.s19.e3" id="DrugDDI.d269.s19.p5" interaction="false"/><negationtags>In vitro studies: Vardenafil and its metabolites had &lt;xcope&gt;&lt;cue&gt;no&lt;/cue&gt; effect on CYP1A2&lt;/xcope&gt;, 2A6, and 2E1 (Ki 100uM).</negationtags></sentence><sentence id="DrugDDI.d269.s20" origId="s20" text="Weak inhibitory effects toward other isoforms (CYP2C8, 2C9, 2C19, 2D6, 3A4) were found, but Ki values were in excess of plasma concentrations achieved following dosing."><entity charOffset="37-45" id="DrugDDI.d269.s20.e0" origId="s20.p234" text="isoforms" type="drug"/><entity charOffset="47-53" id="DrugDDI.d269.s20.e1" origId="s20.p236" text="CYP2C8" type="drug"/><pair e1="DrugDDI.d269.s20.e0" e2="DrugDDI.d269.s20.e1" id="DrugDDI.d269.s20.p0" interaction="false"/></sentence><sentence id="DrugDDI.d269.s21" origId="s21" text="The most potent inhibitory activity was observed for vardenafil metabolite M1, which had a Ki of 1.4 uM toward CYP3A4, which is about 20 times higher than the M1 Cmax values after an 80 mg Vardenafil dose."><entity charOffset="53-63" id="DrugDDI.d269.s21.e0" origId="s21.p256" text="vardenafil" type="drug"/><entity charOffset="111-117" id="DrugDDI.d269.s21.e1" origId="s21.p261" text="CYP3A4" type="drug"/><entity charOffset="189-199" id="DrugDDI.d269.s21.e2" origId="s21.p266" text="Vardenafil" type="drug"/><pair e1="DrugDDI.d269.s21.e0" e2="DrugDDI.d269.s21.e1" id="DrugDDI.d269.s21.p0" interaction="false"/><pair e1="DrugDDI.d269.s21.e0" e2="DrugDDI.d269.s21.e2" id="DrugDDI.d269.s21.p1" interaction="false"/><pair e1="DrugDDI.d269.s21.e1" e2="DrugDDI.d269.s21.e2" id="DrugDDI.d269.s21.p2" interaction="false"/></sentence><sentence id="DrugDDI.d269.s22" origId="s22" text="In vivo studies: Nitrates: The blood pressure lowering effects of sublingual nitrates (0.4 mg) taken 1 and 4 hours after vardenafil and increases in heart rate when taken at 1, 4 and 8 hours were potentiated by a 20 mg dose of Vardenafil in healthy middle-aged subjects."><entity charOffset="17-25" id="DrugDDI.d269.s22.e0" origId="s22.p269" text="Nitrates" type="drug"/><entity charOffset="77-85" id="DrugDDI.d269.s22.e1" origId="s22.p272" text="nitrates" type="drug"/><entity charOffset="121-131" id="DrugDDI.d269.s22.e2" origId="s22.p280" text="vardenafil" type="drug"/><entity charOffset="227-237" id="DrugDDI.d269.s22.e3" origId="s22.p293" text="Vardenafil" type="drug"/><pair e1="DrugDDI.d269.s22.e0" e2="DrugDDI.d269.s22.e1" id="DrugDDI.d269.s22.p0" interaction="false"/><pair e1="DrugDDI.d269.s22.e0" e2="DrugDDI.d269.s22.e2" id="DrugDDI.d269.s22.p1" interaction="false"/><pair e1="DrugDDI.d269.s22.e0" e2="DrugDDI.d269.s22.e3" id="DrugDDI.d269.s22.p2" interaction="false"/><pair e1="DrugDDI.d269.s22.e1" e2="DrugDDI.d269.s22.e2" id="DrugDDI.d269.s22.p3" interaction="false"/><pair e1="DrugDDI.d269.s22.e1" e2="DrugDDI.d269.s22.e3" id="DrugDDI.d269.s22.p4" interaction="false"/><pair e1="DrugDDI.d269.s22.e2" e2="DrugDDI.d269.s22.e3" id="DrugDDI.d269.s22.p5" interaction="false"/></sentence><sentence id="DrugDDI.d269.s23" origId="s23" text="These effects were not observed when Vardenafil 20 mg was taken 24 hours before the NTG."><entity charOffset="37-53" id="DrugDDI.d269.s23.e0" origId="s23.p300" text="Vardenafil 20 mg" type="drug"/><negationtags>&lt;xcope&gt;These effects were &lt;cue&gt;not&lt;/cue&gt; observed when Vardenafil 20 mg was taken 24 hours before the NTG&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d269.s24" origId="s24" text="Potentiation of the hypotensive effects of nitrates for patients with ischemic heart disease has not been evaluated, and concomitant use of Vardenafil and nitrates is contraindicated."><entity charOffset="43-51" id="DrugDDI.d269.s24.e0" origId="s24.p307" text="nitrates" type="drug"/><entity charOffset="140-150" id="DrugDDI.d269.s24.e1" origId="s24.p317" text="Vardenafil" type="drug"/><entity charOffset="155-163" id="DrugDDI.d269.s24.e2" origId="s24.p319" text="nitrates" type="drug"/><pair e1="DrugDDI.d269.s24.e0" e2="DrugDDI.d269.s24.e1" id="DrugDDI.d269.s24.p0" interaction="false"/><pair e1="DrugDDI.d269.s24.e0" e2="DrugDDI.d269.s24.e2" id="DrugDDI.d269.s24.p1" interaction="false"/><pair e1="DrugDDI.d269.s24.e1" e2="DrugDDI.d269.s24.e2" id="DrugDDI.d269.s24.p2" interaction="true"/><negationtags>Potentiation of the hypotensive effects of nitrates for patients with ischemic heart disease has &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; been evaluated&lt;/xcope&gt;, and concomitant use of Vardenafil and nitrates is contraindicated.</negationtags></sentence><sentence id="DrugDDI.d269.s25" origId="s25" text="Nifedipine: Vardenafil 20 mg, when co-administered with slow-release nifedipine 30 mg or 60 mg once daily, did not affect the relative bioavailability (AUC) or maximum concentration (Cmax) of nifedipine, a drug that is metabolized via CYP3A4."><entity charOffset="0-10" id="DrugDDI.d269.s25.e0" origId="s25.p322" text="Nifedipine" type="drug"/><entity charOffset="12-28" id="DrugDDI.d269.s25.e1" origId="s25.p324" text="Vardenafil 20 mg" type="drug"/><entity charOffset="69-85" id="DrugDDI.d269.s25.e2" origId="s25.p327" text="nifedipine 30 mg" type="drug"/><entity charOffset="192-202" id="DrugDDI.d269.s25.e3" origId="s25.p344" text="nifedipine" type="drug"/><entity charOffset="206-210" id="DrugDDI.d269.s25.e4" origId="s25.p345" text="drug" type="drug"/><entity charOffset="235-241" id="DrugDDI.d269.s25.e5" origId="s25.p349" text="CYP3A4" type="drug"/><pair e1="DrugDDI.d269.s25.e0" e2="DrugDDI.d269.s25.e1" id="DrugDDI.d269.s25.p0" interaction="false"/><pair e1="DrugDDI.d269.s25.e0" e2="DrugDDI.d269.s25.e2" id="DrugDDI.d269.s25.p1" interaction="false"/><pair e1="DrugDDI.d269.s25.e0" e2="DrugDDI.d269.s25.e3" id="DrugDDI.d269.s25.p2" interaction="false"/><pair e1="DrugDDI.d269.s25.e0" e2="DrugDDI.d269.s25.e4" id="DrugDDI.d269.s25.p3" interaction="false"/><pair e1="DrugDDI.d269.s25.e0" e2="DrugDDI.d269.s25.e5" id="DrugDDI.d269.s25.p4" interaction="false"/><pair e1="DrugDDI.d269.s25.e1" e2="DrugDDI.d269.s25.e2" id="DrugDDI.d269.s25.p5" interaction="false"/><pair e1="DrugDDI.d269.s25.e1" e2="DrugDDI.d269.s25.e3" id="DrugDDI.d269.s25.p6" interaction="false"/><pair e1="DrugDDI.d269.s25.e1" e2="DrugDDI.d269.s25.e4" id="DrugDDI.d269.s25.p7" interaction="false"/><pair e1="DrugDDI.d269.s25.e1" e2="DrugDDI.d269.s25.e5" id="DrugDDI.d269.s25.p8" interaction="false"/><pair e1="DrugDDI.d269.s25.e2" e2="DrugDDI.d269.s25.e3" id="DrugDDI.d269.s25.p9" interaction="false"/><pair e1="DrugDDI.d269.s25.e2" e2="DrugDDI.d269.s25.e4" id="DrugDDI.d269.s25.p10" interaction="false"/><pair e1="DrugDDI.d269.s25.e2" e2="DrugDDI.d269.s25.e5" id="DrugDDI.d269.s25.p11" interaction="false"/><pair e1="DrugDDI.d269.s25.e3" e2="DrugDDI.d269.s25.e4" id="DrugDDI.d269.s25.p12" interaction="false"/><pair e1="DrugDDI.d269.s25.e3" e2="DrugDDI.d269.s25.e5" id="DrugDDI.d269.s25.p13" interaction="false"/><pair e1="DrugDDI.d269.s25.e4" e2="DrugDDI.d269.s25.e5" id="DrugDDI.d269.s25.p14" interaction="false"/><negationtags>Nifedipine: Vardenafil 20 mg, when co-administered with slow-release nifedipine 30 mg or 60 mg once daily, did &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; affect the relative bioavailability (AUC) or maximum concentration (Cmax) of nifedipine&lt;/xcope&gt;, a drug that is metabolized via CYP3A4.</negationtags></sentence><sentence id="DrugDDI.d269.s26" origId="s26" text="Nifedipine did not alter the plasma levels of Vardenafil when taken in combination."><entity charOffset="0-10" id="DrugDDI.d269.s26.e0" origId="s26.p350" text="Nifedipine" type="drug"/><entity charOffset="46-56" id="DrugDDI.d269.s26.e1" origId="s26.p355" text="Vardenafil" type="drug"/><pair e1="DrugDDI.d269.s26.e0" e2="DrugDDI.d269.s26.e1" id="DrugDDI.d269.s26.p0" interaction="false"/><negationtags>Nifedipine did &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; alter the plasma levels of Vardenafil when taken in combination&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d269.s27" origId="s27" text="In these patients whose hypertension was controlled with nifedipine, Vardenafil 20 mg produced mean additional supine systolic/diastolic blood pressure reductions of 6/5 mm Hg compared to placebo."><entity charOffset="57-67" id="DrugDDI.d269.s27.e0" origId="s27.p363" text="nifedipine" type="drug"/><entity charOffset="69-85" id="DrugDDI.d269.s27.e1" origId="s27.p364" text="Vardenafil 20 mg" type="drug"/><pair e1="DrugDDI.d269.s27.e0" e2="DrugDDI.d269.s27.e1" id="DrugDDI.d269.s27.p0" interaction="true"/></sentence><sentence id="DrugDDI.d269.s28" origId="s28" text="Alpha-blockers: When Vardenafil 10 or 20 mg was given to healthy volunteers either simultaneously or 6 hours after a 10 mg dose of terazosin, significant hypotension developed in a substantial number of subjects."><entity charOffset="21-31" id="DrugDDI.d269.s28.e0" origId="s28.p374" text="Vardenafil" type="drug"/><entity charOffset="131-140" id="DrugDDI.d269.s28.e1" origId="s28.p385" text="terazosin" type="drug"/><pair e1="DrugDDI.d269.s28.e0" e2="DrugDDI.d269.s28.e1" id="DrugDDI.d269.s28.p0" interaction="true"/></sentence><sentence id="DrugDDI.d269.s29" origId="s29" text="With simultaneous dosing of Vardenafil 10 mg and terazosin 10 mg, 6 of 8 subjects experienced a standing systolic blood pressure of less than 85 mm Hg."><entity charOffset="28-44" id="DrugDDI.d269.s29.e0" origId="s29.p391" text="Vardenafil 10 mg" type="drug"/><entity charOffset="49-62" id="DrugDDI.d269.s29.e1" origId="s29.p393" text="terazosin 10" type="drug"/><pair e1="DrugDDI.d269.s29.e0" e2="DrugDDI.d269.s29.e1" id="DrugDDI.d269.s29.p0" interaction="true"/></sentence><sentence id="DrugDDI.d269.s30" origId="s30" text="With simultaneous dosing of Vardenafil 20 mg and terazosin 10 mg, 2 of 9 subjects experienced a standing systolic blood pressure of less than 85 mm Hg."><entity charOffset="28-44" id="DrugDDI.d269.s30.e0" origId="s30.p401" text="Vardenafil 20 mg" type="drug"/><entity charOffset="49-62" id="DrugDDI.d269.s30.e1" origId="s30.p403" text="terazosin 10" type="drug"/><pair e1="DrugDDI.d269.s30.e0" e2="DrugDDI.d269.s30.e1" id="DrugDDI.d269.s30.p0" interaction="true"/></sentence><sentence id="DrugDDI.d269.s31" origId="s31" text="When Vardenafil dosing was separated from terazosin 10 mg by 6 hours, 7 of 28 subjects who received 20 mg of Vardenafil experienced a decrease in standing systolic blood pressure below 85 mm Hg."><entity charOffset="5-15" id="DrugDDI.d269.s31.e0" origId="s31.p411" text="Vardenafil" type="drug"/><entity charOffset="42-55" id="DrugDDI.d269.s31.e1" origId="s31.p414" text="terazosin 10" type="drug"/><entity charOffset="109-119" id="DrugDDI.d269.s31.e2" origId="s31.p421" text="Vardenafil" type="drug"/><pair e1="DrugDDI.d269.s31.e0" e2="DrugDDI.d269.s31.e1" id="DrugDDI.d269.s31.p0" interaction="false"/><pair e1="DrugDDI.d269.s31.e0" e2="DrugDDI.d269.s31.e2" id="DrugDDI.d269.s31.p1" interaction="false"/><pair e1="DrugDDI.d269.s31.e1" e2="DrugDDI.d269.s31.e2" id="DrugDDI.d269.s31.p2" interaction="false"/></sentence><sentence id="DrugDDI.d269.s32" origId="s32" text="In a similar study with tamsulosin in healthy volunteers, 1 of 24 subjects dosed with Vardenafil 20 mg and tamsulosin 0.4 mg separated by 6 hours experienced a standing systolic blood pressure below 85 mm Hg."><entity charOffset="24-34" id="DrugDDI.d269.s32.e0" origId="s32.p427" text="tamsulosin" type="drug"/><entity charOffset="86-102" id="DrugDDI.d269.s32.e1" origId="s32.p432" text="Vardenafil 20 mg" type="drug"/><entity charOffset="107-124" id="DrugDDI.d269.s32.e2" origId="s32.p434" text="tamsulosin 0.4 mg" type="drug"/><pair e1="DrugDDI.d269.s32.e0" e2="DrugDDI.d269.s32.e1" id="DrugDDI.d269.s32.p0" interaction="false"/><pair e1="DrugDDI.d269.s32.e0" e2="DrugDDI.d269.s32.e2" id="DrugDDI.d269.s32.p1" interaction="false"/><pair e1="DrugDDI.d269.s32.e1" e2="DrugDDI.d269.s32.e2" id="DrugDDI.d269.s32.p2" interaction="false"/></sentence><sentence id="DrugDDI.d269.s33" origId="s33" text="Two of 16 subjects dosed simultaneously with Vardenafil 10 mg and tamsulosin 0.4 mg experienced a standing systolic blood pressure below 85 mm Hg."><entity charOffset="45-61" id="DrugDDI.d269.s33.e0" origId="s33.p444" text="Vardenafil 10 mg" type="drug"/><entity charOffset="66-83" id="DrugDDI.d269.s33.e1" origId="s33.p446" text="tamsulosin 0.4 mg" type="drug"/><pair e1="DrugDDI.d269.s33.e0" e2="DrugDDI.d269.s33.e1" id="DrugDDI.d269.s33.p0" interaction="true"/></sentence><sentence id="DrugDDI.d269.s34" origId="s34" text="The administration of lower doses of Vardenafil with alpha-blockers has not been completely evaluated to determine if they can be safely administered together."><entity charOffset="37-47" id="DrugDDI.d269.s34.e0" origId="s34.p452" text="Vardenafil" type="drug"/><negationtags>&lt;xcope&gt;The administration of lower doses of Vardenafil with alpha-blockers has &lt;cue&gt;not&lt;/cue&gt; been completely evaluated to determine if they can be safely administered together&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d269.s35" origId="s35" text="Based on these data, Vardenafil should not be used in patients on alpha-blocker therapy."><entity charOffset="21-31" id="DrugDDI.d269.s35.e0" origId="s35.p469" text="Vardenafil" type="drug"/><entity charOffset="66-80" id="DrugDDI.d269.s35.e1" origId="s35.p475" text="alpha-blocker" type="drug"/><pair e1="DrugDDI.d269.s35.e0" e2="DrugDDI.d269.s35.e1" id="DrugDDI.d269.s35.p0" interaction="true"/><negationtags>Based on these data, Vardenafil should &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; be used in patients on alpha-blocker therapy&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d269.s36" origId="s36" text="Ritonavir and indinavir: Upon concomitant administration of 5 mg of Vardenafil with 600 mg BID ritonavir, the Cmax and AUC of ritonavir were reduced by approximately 20%."><entity charOffset="0-9" id="DrugDDI.d269.s36.e0" origId="s36.p476" text="Ritonavir" type="drug"/><entity charOffset="14-23" id="DrugDDI.d269.s36.e1" origId="s36.p478" text="indinavir" type="drug"/><entity charOffset="68-78" id="DrugDDI.d269.s36.e2" origId="s36.p482" text="Vardenafil" type="drug"/><entity charOffset="95-104" id="DrugDDI.d269.s36.e3" origId="s36.p483" text="ritonavir" type="drug"/><entity charOffset="126-135" id="DrugDDI.d269.s36.e4" origId="s36.p487" text="ritonavir" type="drug"/><pair e1="DrugDDI.d269.s36.e0" e2="DrugDDI.d269.s36.e1" id="DrugDDI.d269.s36.p0" interaction="false"/><pair e1="DrugDDI.d269.s36.e0" e2="DrugDDI.d269.s36.e2" id="DrugDDI.d269.s36.p1" interaction="false"/><pair e1="DrugDDI.d269.s36.e0" e2="DrugDDI.d269.s36.e3" id="DrugDDI.d269.s36.p2" interaction="false"/><pair e1="DrugDDI.d269.s36.e0" e2="DrugDDI.d269.s36.e4" id="DrugDDI.d269.s36.p3" interaction="false"/><pair e1="DrugDDI.d269.s36.e1" e2="DrugDDI.d269.s36.e2" id="DrugDDI.d269.s36.p4" interaction="false"/><pair e1="DrugDDI.d269.s36.e1" e2="DrugDDI.d269.s36.e3" id="DrugDDI.d269.s36.p5" interaction="false"/><pair e1="DrugDDI.d269.s36.e1" e2="DrugDDI.d269.s36.e4" id="DrugDDI.d269.s36.p6" interaction="false"/><pair e1="DrugDDI.d269.s36.e2" e2="DrugDDI.d269.s36.e3" id="DrugDDI.d269.s36.p7" interaction="true"/><pair e1="DrugDDI.d269.s36.e2" e2="DrugDDI.d269.s36.e4" id="DrugDDI.d269.s36.p8" interaction="false"/><pair e1="DrugDDI.d269.s36.e3" e2="DrugDDI.d269.s36.e4" id="DrugDDI.d269.s36.p9" interaction="false"/></sentence><sentence id="DrugDDI.d269.s37" origId="s37" text="Upon administration of 10 mg of Vardenafil with 800 mg TID indinavir, the Cmax and AUC of indinavir were reduced by 40% and 30%, respectively."><entity charOffset="32-42" id="DrugDDI.d269.s37.e0" origId="s37.p493" text="Vardenafil" type="drug"/><entity charOffset="59-68" id="DrugDDI.d269.s37.e1" origId="s37.p494" text="indinavir" type="drug"/><entity charOffset="90-99" id="DrugDDI.d269.s37.e2" origId="s37.p498" text="indinavir" type="drug"/><pair e1="DrugDDI.d269.s37.e0" e2="DrugDDI.d269.s37.e1" id="DrugDDI.d269.s37.p0" interaction="true"/><pair e1="DrugDDI.d269.s37.e0" e2="DrugDDI.d269.s37.e2" id="DrugDDI.d269.s37.p1" interaction="false"/><pair e1="DrugDDI.d269.s37.e1" e2="DrugDDI.d269.s37.e2" id="DrugDDI.d269.s37.p2" interaction="false"/></sentence><sentence id="DrugDDI.d269.s38" origId="s38" text="Alcohol: Alcohol (0.5 g/kg body weight: approximately 40 mL of absolute alcohol in a 70 kg person) and vardenafil plasma levels were not altered when dosed simultaneously."><entity charOffset="0-7" id="DrugDDI.d269.s38.e0" origId="s38.p505" text="Alcohol" type="drug"/><entity charOffset="9-16" id="DrugDDI.d269.s38.e1" origId="s38.p507" text="Alcohol" type="drug"/><entity charOffset="103-113" id="DrugDDI.d269.s38.e2" origId="s38.p517" text="vardenafil" type="drug"/><pair e1="DrugDDI.d269.s38.e0" e2="DrugDDI.d269.s38.e1" id="DrugDDI.d269.s38.p0" interaction="false"/><pair e1="DrugDDI.d269.s38.e0" e2="DrugDDI.d269.s38.e2" id="DrugDDI.d269.s38.p1" interaction="false"/><pair e1="DrugDDI.d269.s38.e1" e2="DrugDDI.d269.s38.e2" id="DrugDDI.d269.s38.p2" interaction="false"/><negationtags>Alcohol: Alcohol (0.5 &lt;xcope&gt;g/kg body weight: approximately 40 mL of absolute alcohol in a 70 kg person) and vardenafil plasma levels were &lt;cue&gt;not&lt;/cue&gt; altered when dosed simultaneously&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d269.s39" origId="s39" text="Vardenafil (20 mg) did not potentiate the hypotensive effects of alcohol during the 4-hour observation period in healthy volunteers when administered with alcohol (0.5 g/kg body weight)."><entity charOffset="0-10" id="DrugDDI.d269.s39.e0" origId="s39.p524" text="Vardenafil" type="drug"/><entity charOffset="65-72" id="DrugDDI.d269.s39.e1" origId="s39.p532" text="alcohol" type="drug"/><entity charOffset="155-162" id="DrugDDI.d269.s39.e2" origId="s39.p537" text="alcohol" type="drug"/><pair e1="DrugDDI.d269.s39.e0" e2="DrugDDI.d269.s39.e1" id="DrugDDI.d269.s39.p0" interaction="false"/><pair e1="DrugDDI.d269.s39.e0" e2="DrugDDI.d269.s39.e2" id="DrugDDI.d269.s39.p1" interaction="false"/><pair e1="DrugDDI.d269.s39.e1" e2="DrugDDI.d269.s39.e2" id="DrugDDI.d269.s39.p2" interaction="false"/><negationtags>Vardenafil (20 mg) did &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; potentiate the hypotensive effects of alcohol during the 4-hour observation period in healthy volunteers when administered with alcohol (0.5 g/kg body weight)&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d269.s40" origId="s40" text="Aspirin: Vardenafil (10 mg and 20 mg) did not potentiate the increase in bleeding time caused by aspirin (two 81 mg tablets)."><entity charOffset="0-7" id="DrugDDI.d269.s40.e0" origId="s40.p542" text="Aspirin" type="drug"/><entity charOffset="9-19" id="DrugDDI.d269.s40.e1" origId="s40.p544" text="Vardenafil" type="drug"/><entity charOffset="97-104" id="DrugDDI.d269.s40.e2" origId="s40.p556" text="aspirin" type="drug"/><pair e1="DrugDDI.d269.s40.e0" e2="DrugDDI.d269.s40.e1" id="DrugDDI.d269.s40.p0" interaction="false"/><pair e1="DrugDDI.d269.s40.e0" e2="DrugDDI.d269.s40.e2" id="DrugDDI.d269.s40.p1" interaction="false"/><pair e1="DrugDDI.d269.s40.e1" e2="DrugDDI.d269.s40.e2" id="DrugDDI.d269.s40.p2" interaction="false"/><negationtags>Aspirin: Vardenafil (10 mg and 20 mg) did &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; potentiate the increase in bleeding time caused by aspirin (two 81 mg tablets)&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d269.s41" origId="s41" text="Other interactions: Vardenafil had no effect on the pharmacodynamics of glyburide (glucose and insulin concentrations) and warfarin (prothrombin time or other pharmacodynamic parameters)."><entity charOffset="20-30" id="DrugDDI.d269.s41.e0" origId="s41.p562" text="Vardenafil" type="drug"/><entity charOffset="72-81" id="DrugDDI.d269.s41.e1" origId="s41.p566" text="glyburide" type="drug"/><entity charOffset="83-90" id="DrugDDI.d269.s41.e2" origId="s41.p568" text="glucose" type="drug"/><entity charOffset="95-102" id="DrugDDI.d269.s41.e3" origId="s41.p570" text="insulin" type="drug"/><entity charOffset="123-131" id="DrugDDI.d269.s41.e4" origId="s41.p573" text="warfarin" type="drug"/><pair e1="DrugDDI.d269.s41.e0" e2="DrugDDI.d269.s41.e1" id="DrugDDI.d269.s41.p0" interaction="false"/><pair e1="DrugDDI.d269.s41.e0" e2="DrugDDI.d269.s41.e2" id="DrugDDI.d269.s41.p1" interaction="false"/><pair e1="DrugDDI.d269.s41.e0" e2="DrugDDI.d269.s41.e3" id="DrugDDI.d269.s41.p2" interaction="false"/><pair e1="DrugDDI.d269.s41.e0" e2="DrugDDI.d269.s41.e4" id="DrugDDI.d269.s41.p3" interaction="false"/><pair e1="DrugDDI.d269.s41.e1" e2="DrugDDI.d269.s41.e2" id="DrugDDI.d269.s41.p4" interaction="false"/><pair e1="DrugDDI.d269.s41.e1" e2="DrugDDI.d269.s41.e3" id="DrugDDI.d269.s41.p5" interaction="false"/><pair e1="DrugDDI.d269.s41.e1" e2="DrugDDI.d269.s41.e4" id="DrugDDI.d269.s41.p6" interaction="false"/><pair e1="DrugDDI.d269.s41.e2" e2="DrugDDI.d269.s41.e3" id="DrugDDI.d269.s41.p7" interaction="false"/><pair e1="DrugDDI.d269.s41.e2" e2="DrugDDI.d269.s41.e4" id="DrugDDI.d269.s41.p8" interaction="false"/><pair e1="DrugDDI.d269.s41.e3" e2="DrugDDI.d269.s41.e4" id="DrugDDI.d269.s41.p9" interaction="false"/><negationtags>Other interactions: Vardenafil had &lt;xcope&gt;&lt;cue&gt;no&lt;/cue&gt; effect on the pharmacodynamics of glyburide (glucose and insulin concentrations) and warfarin (prothrombin time or other pharmacodynamic parameters)&lt;/xcope&gt;.</negationtags></sentence></document>